|
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
|
5R01CA206012-02
|
$402,548
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 Addressing Rural Cancer Health Disparities: An SCC-SIUSM Partnership
|
5P20CA192987-03
|
$212,906
|
BRARD, LAURENT
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
2/2 Addressing Rural Cancer Health Disparities: an SCC-SIUSM Partnership
|
5P20CA192966-03
|
$176,953
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
A novel approach for the selective inhibition of HIF-2a in kidney cancer
|
1R01CA217905-01
|
$348,203
|
KOH, MEI YEE
|
UNIVERSITY OF UTAH
|
|
A Pathway of Tumor Suppression
|
2R01CA047296-29
|
$366,000
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Anastasis, a new mechanism driving cell survival and evolution
|
5DP1CA195760-04
|
$767,500
|
MONTELL, DENISE
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Area C: Functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies
|
1R33CA225281-01
|
$1,491,750
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
N/A
|
DCEG (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
Custer, Mary
|
CCR (NCI)
|
|
Bench to bedside: non-invasive treatment of tumors in children
|
1U01CA202947-01A1
|
$350,585
|
KIM, PETER
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$362,249
|
Buck, Christopher
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-04
|
$519,002
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer cell adaptation to metabolic stress
|
5P01CA104838-14
|
$1,159,608
|
SIMON, M.
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-46
|
$3,572,644
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA016086-41S1
|
$125,000
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-41S2
|
$200,180
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-41S3
|
$126,017
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-41S4
|
$62,502
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA016086-41
|
$7,114,974
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016042-42S1
|
$41,000
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
5P30CA016042-42
|
$4,295,192
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA062203-20
|
$2,317,496
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Cancer Center Support Grant
|
3P30CA077598-19S1
|
$114,438
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA
|
|
Cancer Center Support Grant
|
3P30CA077598-19S2
|
$72,918
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA
|
|
Cancer Center Support Grant
|
3P30CA077598-19S3
|
$104,165
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA
|
|
Cancer Center Support Grant
|
5P30CA077598-19
|
$3,561,178
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S5
|
$113,563
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|